Girard Stéphane D, Jacquet Marlyse, Baranger Kévin, Migliorati Martine, Escoffier Guy, Bernard Anne, Khrestchatisky Michel, Féron François, Rivera Santiago, Roman François S, Marchetti Evelyne
Aix Marseille Université, CNRS, NICN, UMR7259, Marseille, France.
Hippocampus. 2014 Jul;24(7):762-72. doi: 10.1002/hipo.22267. Epub 2014 Mar 14.
The 5XFAD mice are an early-onset transgenic model of Alzheimer's disease (AD) in which amyloid plaques are first observed between two and four months of age in the cortical layer five and in the subiculum of the hippocampal formation. Although cognitive alterations have been described in these mice, there are no studies that focused on the onset of hippocampus-dependent memory deficits, which are a hallmark of the prodromal stage of AD. To identify when the first learning and memory impairments appear, 5XFAD mice of two, four, and six months of age were compared with their respective wild-type littermates using the olfactory tubing maze, which is a very sensitive hippocampal-dependent task. Deficits in learning and memory started at four months with a substantial increase at six months of age while no olfactory impairments were observed. The volumetric study using magnetic resonance imaging of the whole brain and specific areas (olfactory bulb, striatum, and hippocampus) did not reveal neuro-anatomical difference. Slight memory deficits appeared at 4 months of age in correlation with an increased astrogliosis and amyloid plaque formation. This early impairment in learning and memory related to the hippocampal dysfunction is particularly suited to assess preclinical therapeutic strategies aiming to delay or suppress the onset of AD.
5XFAD小鼠是阿尔茨海默病(AD)的早发型转基因模型,在该模型中,淀粉样斑块最早在2至4月龄时出现在大脑皮层第5层和海马结构的下托。尽管已在这些小鼠中描述了认知改变,但尚无研究聚焦于海马依赖性记忆缺陷的发病情况,而海马依赖性记忆缺陷是AD前驱期的一个标志。为了确定首次出现学习和记忆障碍的时间,使用嗅觉管迷宫(一种非常敏感的海马依赖性任务),将2、4和6月龄的5XFAD小鼠与其各自的野生型同窝小鼠进行比较。学习和记忆缺陷在4月龄时开始出现,6月龄时大幅增加,而未观察到嗅觉障碍。使用全脑及特定区域(嗅球、纹状体和海马)的磁共振成像进行的体积研究未发现神经解剖学差异。4月龄时出现轻微记忆缺陷,同时伴有星形胶质细胞增生和淀粉样斑块形成增加。这种与海马功能障碍相关的早期学习和记忆损伤特别适合评估旨在延迟或抑制AD发病的临床前治疗策略。